Actively Recruiting

Age: 18Years - 50Years
All Genders
Healthy Volunteers
NCT04871932

COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics

Led by RenJi Hospital · Updated on 2021-06-03

50

Participants Needed

1

Research Sites

304 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In recent years, single-cell high-throughput sequencing technology has developed rapidly and is widely used in research related to the immune system, breaking traditional cognition and gaining a new understanding of immune cell classification. In particular, the emerging single cell RNA sequencing (scRNA-seq) provides new ideas for the study of cell heterogeneity in multicellular organisms. Analyzing the changes in the expression profile of the cell transcriptome at the single-cell level can clearly show the changes in the trajectory of individual cells, reveal new cell types, and discover the potential functions of immune cells. Therefore, this study intends to recruit healthy adults and use multi-omics techniques such as single-cell sequencing to systematically classify the peripheral blood mononuclear cells of healthy adults to provide a basis for further disease-related research.

CONDITIONS

Official Title

COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics

Who Can Participate

Age: 18Years - 50Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age from 18 to 50 years
  • No history of major diseases
  • No bacterial or viral infection in the past 3 months
  • No recent surgery or trauma
  • No history of smoking or alcoholism
  • No immune system disease
Not Eligible

You will not qualify if you...

  • Infectious diseases
  • Tumor diseases
  • Hematological diseases
  • History of hypertension and diabetes
  • Autoimmune diseases
  • History of liver and kidney insufficiency
  • History of cardiovascular diseases
  • Pregnancy or breast-feeding
  • Past and current use of immunosuppressive drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cardiology, Ren Ji Hospital

Shanghai, China

Actively Recruiting

Loading map...

Research Team

J

Jun Pu, MD,PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here